What is Seer Inc?
, a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 87.63M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.